Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03275623 · ClinicalTrials.gov registry record · Phase 4
Management of Sub-Clinical Bacteriuria in Pregnancy
A Phase 4 study of Pyelonephritis and Cystitis, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT03275623: Completed Phase 4 study of Pyelonephritis and Cystitis, sponsored by The University of Texas Health Science Center, Houston.
NCT03275623 is a Phase 4 study of Pyelonephritis and Cystitis that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 60 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03275623, a Phase 4 study of Pyelonephritis and Cystitis, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine if treatment of pregnant women with urine cultures with a low level of bacteria (less than 100,000 colony forming units (CFU)) may decrease adverse pregnancy outcomes.
Primary Outcome
Cystitis is defined as a urine culture with \>100,000 CFU at any point during antenatal care.
Conditions Studied
Interventions
- DRUG Antibiotic
- OTHER Standard Prenatal Care
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-09-15 |
| Est. Completion | 2019-03-18 |
| Phase | Phase 4 |
What the finished NCT03275623 record still lists
NCT03275623 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower).
The record links to 3 conditions, with Pyelonephritis appearing as the primary indexed condition, and to 2 interventions - of which Antibiotic is the first listed.
NCT03275623 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03275623 about?
NCT03275623 is a clinical study titled "Management of Sub-Clinical Bacteriuria in Pregnancy". The purpose of the study is to determine if treatment of pregnant women with urine cultures with a low level of bacteria (less than 100,000 colony forming units (CFU)) may decrease adverse pregnancy outcomes.
What is the current status of trial NCT03275623?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2017-09-15. Estimated completion is 2019-03-18.
What conditions does trial NCT03275623 study?
This clinical trial studies the following conditions: Pyelonephritis, Cystitis, Cystitis;Puerperium.
What interventions are being tested in trial NCT03275623?
The interventions under investigation include: Antibiotic (DRUG), Standard Prenatal Care (OTHER).
Who is sponsoring clinical trial NCT03275623?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03275623 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pyelonephritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03275623's enrollment target sits among peer trials
60 1125th of 2000 higher than 799 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI